Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial

oleh: Erwann P. Loret, Albert Darque, Elvenn A. Loret, Corinne Nicolino-Brunet, Sophie Morange, Elisabeth Castagnier, Josiane Casanova, Christine Caloustian, Charléric Bornet, Julie Coussirou, Jihen Bousseta, Bertrand Dussol, Isabelle Ravaux